HIMSS TV

Meg Barron, managing director of engagement and outreach at Peterson Health Technology Institute, highlights how the organization independently evaluates digital health offerings and its recent report on digital musculoskeletal solutions.

Amos Adler, founder and president of MEMOTEXT, discusses how the company builds and commercializes digital engagement tools, its digital app for schizophrenia and psychosis patients, and Canadian vs. U.S. markets for digital therapeutics.  

Amid the trend of healthcare companies leveraging AI, Jerry Villacres, Manifold's VP of Sales, Cloud Solutions, cautions that they must first implement a sound data strategy to make the most out of those tools.

Mark Polyak, president of global data management at IPSOS, says LLMs can "talk" to patients about administrative tasks like scheduling, but bias and model compatibility must be addressed before clinical deployments.  

Harvard research associate Brian Spisak discusses how a "leadership-first, tech-last" approach can prevent organisations from deploying ticking time bombs.  

Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.  

Rachael Charbonneau, American Heart Association senior program development manager of health science, discusses the Center for Health Technology and Innovation and its training program aimed at improving digital health literacy.  

Lyle McMillin, principal product manager at Hyland, explains how a vendor partner focused on following interoperability standards can help providers work with partner organizations to improve their data exchange.  

Joy Liu, founder and CEO of Plenful, discusses burdens faced by pharmacists, including a shortage of pharmacy technicians and compliance challenges and where AI can step in to alleviate some of the pain.

Ashok Chennuru, global chief data and insights officer at Elevance Health, and Oron Afek, CEO of Vim, discuss scaling artificial intelligence to accelerate workflows, enhance patient care and unlock personalized medicine.